Carina Marquez, MD

Headshot of Carina Marquez
User Profile Photo

Carina Marquez, MD

User Profile Name
Associate Director for Equity, UCSF-Bay Area CFAR
Associate Professor, School of Medicine
User Profile Title
User Profile Email
Visit CTSI Profile

Biography

Dr. Carina Marquez is an Assistant Professor of Medicine in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital (ZSFG) and the Associate Director for Equity in the UCSF Center for AIDS Research. Her research focuses on elucidating TB transmission dynamics in East Africa and developing interventions to improve the TB care continuum. In addition to TB research, her research also focuses on COVID-19 epidemiology in Latinx communities and interventions to reduce disparities. She is a lead investigator in Unidos en Salud, a community-academic partnership between UCSF and the San Francisco Latino Task-COVID 19. She is also the co-PD on a NIH funded RADx-UP initiative to increase uptake of COVID-19 testing in Latinx communities in Merced County and in the Canal District in Marin County. She is also an ID and HIV specialist and directs the SALUD clinic, a clinic within the Positive Health Practice "Ward 86" at ZSFG, that is dedicated to providing multidisciplinary care to LatinX patients with HIV.

User Profile Bio

Displaying 1 - 25 of 58

  1. Marquez C, Chen Y, Atukunda M, Chamie G, Balzer LB, Kironde J, Ssemmondo E, Mwangwa F, Kabami J, Owaraganise A, Kakande E, Abbott R, Ssekyanzi B, Koss C, Kamya MR, Charlebois ED, Havlir DV, Petersen ML. The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in Nine Rural Ugandan Communities. Clin Infect Dis. 2022 Aug 19.
    http://www.ncbi.nlm.nih.gov/pubmed/35982635
  2. Chaisson LH, Semitala FC, Nangobi F, Steinmetz S, Marquez C, Armstrong DT, Opira B, Kamya MR, Phillips PPJ, Dowdy DW, Yoon C. Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3HP. AIDS. 2023 Feb 08.
    http://www.ncbi.nlm.nih.gov/pubmed/36779500
  3. Chamie G, Prado P, Oviedo Y, Vizcaíno T, Arechiga C, Marson K, Carrera O, Alvarado MJ, Corchado CG, Gomez M, Mochel M, de Leon I, Garibay KK, Durazo A, Young MT, Yen IH, Sauceda J, Rojas S, DeRisi J, Petersen M, Havlir DV, Marquez C. Reproducibility and implementation of a rapid, community-based COVID-19 "test and respond" model in low-income, majority-Latino communities in Northern California. PLoS One. 2022; 17(10):e0276257.
    http://www.ncbi.nlm.nih.gov/pubmed/36301834
  4. Marquez C, Kerkhoff AD, Schrom J, Rojas S, Black D, Mitchell A, Wang CY, Pilarowski G, Ribeiro S, Jones D, Payan J, Manganelli S, Rojas S, Lemus J, Jain V, Chamie G, Tulier-Laiwa V, Petersen M, DeRisi J, Havlir DV. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods. JAMA Netw Open. 2022 10 03; 5(10):e2235844.
    http://www.ncbi.nlm.nih.gov/pubmed/36215069
  5. Schrom J, Marquez C, Petersen M, DeRisi J, Havlir D. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge. Ann Intern Med. 2022 Oct; 175(10):W119.
    http://www.ncbi.nlm.nih.gov/pubmed/36252253
  6. Clark EH, Marquez C, Whitman JD, Bern C. Screening for Chagas Disease Should Be Included in Entry-to-Care Testing for At-Risk People With Human Immunodeficiency Virus (HIV) Living in the United States. Clin Infect Dis. 2022 Sep 14; 75(5):901-906.
    http://www.ncbi.nlm.nih.gov/pubmed/35180299
  7. Liu J, Laurie MT, Rubio L, Vazquez SE, Sunshine S, Mitchell AM, Hapte-Selassie M, Mann SA, Pilarowski G, Black D, Marquez C, Rojas S, Lionakis MS, Petersen M, Whitman JD, Jain V, Anderson M, Havlir D, DeRisi J. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics and Immune Responses in a Household of Vaccinated Persons. Clin Infect Dis. 2022 08 24; 75(1):e303-e306.
    http://www.ncbi.nlm.nih.gov/pubmed/35037050
  8. Laurie MT, Liu J, Sunshine S, Peng J, Black D, Mitchell AM, Mann SA, Pilarowski G, Zorn KC, Rubio L, Bravo S, Marquez C, Sabatino JJ, Mittl K, Petersen M, Havlir D, DeRisi J. SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron. J Infect Dis. 2022 06 01; 225(11):1909-1914.
    http://www.ncbi.nlm.nih.gov/pubmed/34979030
  9. Kerkhoff AD, Rojas S, Black D, Ribeiro S, Rojas S, Valencia R, Lemus J, Payan J, Schrom J, Jones D, Manganelli S, Bandi S, Chamie G, Tulier-Laiwa V, Petersen M, Havlir D, Marquez C. Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program. JAMA Netw Open. 2022 05 02; 5(5):e2214163.
    http://www.ncbi.nlm.nih.gov/pubmed/35616939
  10. Acharya CB, Schrom J, Mitchell AM, Coil DA, Marquez C, Rojas S, Wang CY, Liu J, Pilarowski G, Solis L, Georgian E, Belafsky S, Petersen M, DeRisi J, Michelmore R, Havlir D. Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant. Open Forum Infect Dis. 2022 May; 9(5):ofac135.
    http://www.ncbi.nlm.nih.gov/pubmed/35479304
  11. Schrom J, Marquez C, Pilarowski G, Wang CY, Mitchell A, Puccinelli R, Black D, Rojas S, Ribeiro S, Tulier-Laiwa V, Martinez J, Payan J, Rojas S, Jones D, Martinez D, Nakamura R, Chamie G, Jain V, Petersen M, DeRisi J, Havlir D. Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge : A Cross-Sectional Study. Ann Intern Med. 2022 05; 175(5):682-690.
    http://www.ncbi.nlm.nih.gov/pubmed/35286144
  12. Kerkhoff AD, Farrand E, Marquez C, Cattamanchi A, Handley MA. Addressing health disparities through implementation science-a need to integrate an equity lens from the outset. Implement Sci. 2022 01 31; 17(1):13.
    http://www.ncbi.nlm.nih.gov/pubmed/35101088
  13. Peng J, Liu J, Mann SA, Mitchell AM, Laurie MT, Sunshine S, Pilarowski G, Ayscue P, Kistler A, Vanaerschot M, Li LM, McGeever A, Chow ED, Marquez C, Nakamura R, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Naso J, Schwab J, Petersen M, Havlir D, DeRisi J, IDseq Team . Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco. Clin Infect Dis. 2021 03 31.
    http://www.ncbi.nlm.nih.gov/pubmed/33788923
  14. Jakubowski A, Kabami J, Balzer LB, Ayieko J, Charlebois ED, Owaraganise A, Marquez C, Clark TD, Black D, Shade SB, Chamie G, Cohen CR, Bukusi EA, Kamya MR, Petersen M, Havlir DV, Thirumurthy H. Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial. Lancet Glob Health. 2022 01; 10(1):e96-e104.
    http://www.ncbi.nlm.nih.gov/pubmed/34919862
  15. Laurie MT, Liu J, Sunshine S, Peng J, Black D, Mitchell AM, Mann SA, Pilarowski G, Zorn KC, Rubio L, Bravo S, Marquez C, Sabatino JJ, Mittl K, Petersen M, Havlir D, DeRisi J. SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron. medRxiv. 2021 Dec 22.
    http://www.ncbi.nlm.nih.gov/pubmed/34981075
  16. Naso J, Rojas S, Peng J, Marquez C, Contreras M, Castellanos E, Rojas S, Rubio L, Jones D, Jacobo J, Black D, Tulier-Laiwa V, Martinez J, Chamie G, Pilarowski G, DeRisi J, Havlir D, Petersen M. High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community. Health Equity. 2021; 5(1):840-846.
    http://www.ncbi.nlm.nih.gov/pubmed/35018317
  17. Pilarowski G, Marquez C, Rubio L, Peng J, Martinez J, Black D, Chamie G, Jones D, Jacobo J, Tulier-Laiwa V, Rojas S, Rojas S, Cox C, Petersen M, DeRisi J, Havlir DV. Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing. Clin Infect Dis. 2020 Dec 26.
    http://www.ncbi.nlm.nih.gov/pubmed/33367619
  18. Marquez C, Kerkhoff AD, Naso J, Contreras MG, Castellanos Diaz E, Rojas S, Peng J, Rubio L, Jones D, Jacobo J, Rojas S, Gonzalez R, Fuchs JD, Black D, Ribeiro S, Nossokoff J, Tulier-Laiwa V, Martinez J, Chamie G, Pilarowski G, DeRisi J, Petersen M, Havlir DV. A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice. PLoS One. 2021; 16(9):e0257111.
    http://www.ncbi.nlm.nih.gov/pubmed/34543291
  19. van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Le Voyer T, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ, UCSF COMET consortium . Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021 09 22; 13(612):eabh2624.
    http://www.ncbi.nlm.nih.gov/pubmed/34429372
  20. Santiago-Rodríguez EI, Rivas CE, Maiorana A, Pérez AE, Erguera X, Johnson MO, Christopoulos KA, Marquez C, Sauceda JA. Unpacking the "backpack of shame": Exploring intersections of stigma among Latinx people living with HIV in San Francisco, CA. Cultur Divers Ethnic Minor Psychol. 2021 Aug 19.
    http://www.ncbi.nlm.nih.gov/pubmed/34410754
  21. Chamie G, Marquez C, Crawford E, Peng J, Petersen M, Schwab D, Schwab J, Martinez J, Jones D, Black D, Gandhi M, Kerkhoff AD, Jain V, Sergi F, Jacobo J, Rojas S, Tulier-Laiwa V, Gallardo-Brown T, Appa A, Chiu C, Rodgers M, Hackett J, CLIAhub Consortium , Kistler A, Hao S, Kamm J, Dynerman D, Batson J, Greenhouse B, DeRisi J, Havlir DV. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco. Clin Infect Dis. 2021 07 30; 73(Suppl 2):S127-S135.
    http://www.ncbi.nlm.nih.gov/pubmed/32821935
  22. Peng J, Marquez C, Rubio L, Chamie G, Jones D, Jacobo J, Rojas S, Rojas S, Tulier-Laiwa V, Black D, Martinez J, Pilarowski G, Cox C, Derisi J, Havlir D, Petersen M. High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco. Open Forum Infect Dis. 2021 Oct; 8(10):ofab202.
    http://www.ncbi.nlm.nih.gov/pubmed/34642635
  23. Pilarowski G, Lebel P, Sunshine S, Liu J, Crawford E, Marquez C, Rubio L, Chamie G, Martinez J, Peng J, Black D, Wu W, Pak J, Laurie MT, Jones D, Miller S, Jacobo J, Rojas S, Rojas S, Nakamura R, Tulier-Laiwa V, Petersen M, Havlir DV, DeRisi J. Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco. J Infect Dis. 2021 04 08; 223(7):1139-1144.
    http://www.ncbi.nlm.nih.gov/pubmed/33394052
  24. van der Wijst MGP, Vazquez SE, Hartoularos GC, Bastard P, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Mann SA, Lynch KL, Yun C, Havlir DV, Chamie G, Marquez C, Greenhouse B, Lionakis MS, Norris PJ, Dumont LJ, Kelly K, Zhang P, Zhang Q, Gervais A, Voyer TL, Whatley A, Si Y, Byrne A, Combes AJ, Rao AA, Song YS, UCSF COMET consortium , Fragiadakis GK, Kangelaris K, Calfee CS, Erle DJ, Hendrickson C, Krummel MF, Woodruff PG, Langelier CR, Casanova JL, Derisi JL, Anderson MS, Ye CJ. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19. bioRxiv. 2021 Mar 10.
    http://www.ncbi.nlm.nih.gov/pubmed/33758859
  25. Koss CA, Havlir DV, Ayieko J, Kwarisiima D, Kabami J, Chamie G, Atukunda M, Mwinike Y, Mwangwa F, Owaraganise A, Peng J, Olilo W, Snyman K, Awuonda B, Clark TD, Black D, Nugent J, Brown LB, Marquez C, Okochi H, Zhang K, Camlin CS, Jain V, Gandhi M, Cohen CR, Bukusi EA, Charlebois ED, Petersen ML, Kamya MR, Balzer LB. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. PLoS Med. 2021 02; 18(2):e1003492.
    http://www.ncbi.nlm.nih.gov/pubmed/33561143